Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy

Clinical Biochemistry

Volumn 36, Issue 7, 2003, Pages 557-562

  Bhatia, Shweta ^a   Shukla, Rimi ^a   Madhu, Sri Venkata ^a   Gambhir, Jasvinder Kaur ^a   Prabhu, Krishna Madhava ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Catalase; Diabetic nephropathy; Malondialdehyde; Nitric oxide; Oxidative stress; Reduced glutathione; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; LIPID; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ASIAN; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEALTH STATUS; HUMAN; INDIAN; KIDNEY DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATIENT; PRIORITY JOURNAL;

EID: 0141884341     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00094-8     Document Type: Article

References (37)

1. Alzaid A.A. Microalbuminuria in patients with NIDDM. An overview. Diabetes Care. 19:1996;79-89.
2. Guigliano D., Paolisso G., Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes. 19:1996;257-267.
3. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Brish Medical Bulletein. 49:1993;481-493.
4. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications (A new perspective to an old paradigm). Diabetes. 48:1999;1-9.
5. Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48:(suppl 51):1995;S18-S21.
6. Lehmann R., Schleicher E.D. Molecular mechanisms of diabetic nephropathy. Clin Chim Acta. 297:2000;135-144.
7. Kashihara N., Watanabe Y., Makino H., et al. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA. 86:1992;6309-6313.
8. Salahudeen A.K., Kanji V., Reckelhoff J.F., Schmidt A.M. Pathogenesis of diabetic nephropathy a radical approach . Nephrol Dial Transplant. 12:1997;664-668.
9. Kedziora-Kornatowska K.Z. Production of superoxide and nitric oxide by granulocytes in non-insulin dependent diabetic patients with and without nephropathy. IUBMB Life. 48:1999;359-362.
10. Freeman B. Free radical chemistry of nitric oxide. Looking at the dark side. Chest. 105:1993;79S-84S.
11. Rubbo H., Radi R., Trujillo M., et al. Nitric oxide regulation of superoxide and peroxynitrite dependent lipid peroxidation. Formation of novel nitrogen containing oxidized lipid derivatives. J Biol Chem. 269:1994;26066-26075.
12. Griesmacher A., Kindhauser M., Andert S.E., et al. Enhanced serum levels of thiobarbituric-acid reactive substances in diabetes mellitus. Am J Med. 98:1995;469-475.
13. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R., Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci. 90:1996;255-260.
14. Collier A., Rumley A., Rumley A.G., et al. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes. 41:1992;909-913.
15. Kedziora-Kornatowska K.Z., Luciak M., Blaszczyk Pawlak W. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes mellitus with or without nephropathy. Nephrol Dial Transplant. 13:1998;2829-2832.
16. Dincer Y., Alademir Z., Ilkova H., Akcay T. Susceptibility of glutathione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes effect of glycemic control . Clin Biochem. 35:2002;297-301.
17. Vijayalingam S., Parthiban A., Shanmugasundaram K.R., Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic Med. 13:1996;715-719.
18. Yoshida K., Hirokawa J., Tagami S., et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus regulation of glutathione synthesis and efflux . Diabetologia. 38:1995;201-210.
19. Ceriello A., Bortolotti N., Falleti E., et al. Total Radical-Trapping Antioxidant Parameter in NIDDM patients. Diabetes Care. 20:1997;194-197.
20. Inouye M., Mio T., Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism. 48:1999;205-209.
21. Nurooz-Zadeh J., Rahimi A., Tajaddini-Sarmadi J., et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 40:1997;647-653.
22. Van der Jagt D.J., Harrison J.M., Ratliff D.M., Hunsaker L.A., Van der Jagt D.L. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem. 34:2001;265-270.
23. Aydin A., Orhan H., Sayal A., Ozata M., Sahin G., Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus effects of glycemic control . Clin Biochem. 34:2001;65-70.
24. Chiarelli F., Cipollone F., Romano F., et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria. Relation to glomerular hyperfiltration. Diabetes. 49:2000;1258-1263.
25. Vanizor B., Orem A., Karahan S.C., et al. Decreased nitric oxide end products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Prac. 54:2001;33-39.
26. Report. Diabetes Care. 20:(7):1997.
27. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by new colorimetric method. Clin Chim Acta. 90:1978;37-43.
28. Moshage H., Kok B., Huizenga J.R., Jansen P.L.M. Nitrite and nitrate determinations in plasma a critical evaluation . Clin Chem. 41:1995;892-896.
29. Guevara I., Iwanejko J., Dembinska-Kiec A., et al. Determination of nitrite/nitrate in human biological material by simple Griess reaction. Clin Chim Acta. 274:1998;177-188.
30. Nandi A., Chaatterjee I.B. Assay of superoxide dismutase activity in animal tissues. J Biosci. 13:1988;305-315.
31. Sinha A.K. Colorimetric assay of catalase. Analytical Biochem. 47:1972;389-394.
32. Beutler E., Duran O., Duarte B.M.K. Improved method for determination of blood glutathione. J Lab Clin Med. 51:1963;882-888.
33. Slatter D.A., Bolton C.H., Bailey A.J. The importance of lipid derived malondialdehyde in diabetes mellitus. Diabetologia. 43:2000;550-557.
34. Hiragushi K., Sugimoto S., Shikata K., et al. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo and microalbuminuric patients with type 2 diabetes mellitus. Diabetes Res Clin Prac. 53:2001;149-159.
35. Ishii N., Patel K.P., Lane P.H., et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 12:2001;1630-1639.
36. Arali K., Lizuka S., Tada Y., et al. Increase in glycosylated form of erythrocyte superoxide dismutase in diabetes and close association of the nonenzymatic glycosylation with the enzyme activity. Biochim Biophys Acta. 924:1987;292-296.
37. Tilton R.G., Chang K., Pugliese G., et al. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes. 38:1989;1258-1270.